Bill

Bill > HR6670


US HR6670

Prescription for American Drug Independence Act of 2020


summary

Introduced
05/01/2020
In Committee
05/01/2020
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

To provide for an exploration of strategies to increase domestic manufacturing and diversify the supply chain of critical drugs, and for other purposes. This bill requires the Department of Health and Human Services to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to (1) establish a committee of experts on drug-supply issues, (2) convene a symposium to recommend strategies for ending U.S. dependence on foreign manufacturing of critical drugs, and (3) report on the symposium's proceedings.

AI Summary

This bill, the Prescription for American Drug Independence Act of 2020, requires the Department of Health and Human Services to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to (1) establish a committee of experts on drug supply issues, (2) convene a public symposium to analyze the impact of U.S. dependence on foreign manufacturing of critical drugs and recommend strategies to end such dependence, and (3) report on the symposium's proceedings. The term "critical drug" refers to life-saving drugs as defined under the Federal Food, Drug, and Cosmetic Act. The goal of the bill is to explore strategies to increase domestic manufacturing and diversify the supply chain of critical drugs to protect the nation from disruptions.

Committee Categories

Business and Industry

Sponsors (8)

Last Action

Referred to the House Committee on Energy and Commerce. (on 05/01/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...